Table 2.
The relationship between pelvic LNM and survival
| Characteristics | Cases, n | Surviving, n (%) | OS, % | P |
|---|---|---|---|---|
| Pelvic LNM (n = 296) | 0.00 | |||
| Negative | 236 | 219 (92.80) | 91 | |
| Positive | 60 | 46 (76.67) | 67 | |
| Number of positive pelvic LNs (n = 60) | 0.04 | |||
| ≤2 | 47 | 39 (82.98) | 76 | |
| >2 | 13 | 7 (53.85) | 35 | |
| Unilateral/bilateral pelvic LNM (n = 60) | 0.45 | |||
| Unilateral pelvic LNM | 36 | 29 (80.56) | 73 | |
| Bilateral pelvic LNM | 24 | 17 (70.83) | 60 | |
| Single group/multiple groups of pelvic LNM (n = 41) | 0.03 | |||
| Single group | 28 | 24 (85.71) | 78 | |
| Multiple groups | 13 | 8 (61.54) | 44 |
LNM: Lymph node metastasis; LNs: Lymph nodes; OS: Overall survival.